<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00259636</url>
  </required_header>
  <id_info>
    <org_study_id>EISAI 51-345-749</org_study_id>
    <nct_id>NCT00259636</nct_id>
  </id_info>
  <brief_title>Zonisamide for Fibromyalgia &amp; Migraine</brief_title>
  <official_title>Zonisamide for Fibromyalgia &amp; Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eisai Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with fibromyalgia &amp; migraine are randomized to receive zonisamide or placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study was not conducted due to logistical problems
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Logistical problems prevented enrollment
  </why_stopped>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue score</measure>
    <time_frame>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</time_frame>
    <description>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tender point count</measure>
    <time_frame>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</time_frame>
    <description>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Headache index</measure>
    <time_frame>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</time_frame>
    <description>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep efficiency</measure>
    <time_frame>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</time_frame>
    <description>assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment</description>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Fibromyalgia</condition>
  <condition>Migraine</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>zonisamide</intervention_name>
    <description>zonisamide 100 mg -300 mg daily vs placebo</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 with fibromyalgia &amp; migraine

        Exclusion Criteria:

          -  allergy sulfa, liver or kidney disease, pregnant or not using contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawn Marcus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2005</study_first_submitted>
  <study_first_submitted_qc>November 26, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2005</study_first_posted>
  <last_update_submitted>May 31, 2011</last_update_submitted>
  <last_update_submitted_qc>May 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dawn Marcus</name_title>
    <organization>University of Pittsburgh</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zonisamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

